IL1B and relapsing-remitting multiple sclerosis: In accord with this hypothesis, our results show that detection of the proinflammatory cytokine IL-1β in the CSF of early RRMS patients at the time of remission was associated with pronounced neuronal damage and accumulating disability in the following years.